Question 15538 — human blood and organs

Summary

Mr. Frank Giletti questions the Minister of Labor, Health and Solidarity on the “plasma 2026” plan proposed by the French Blood Establishment (EFS). Each year, the French Blood Establishment (EFS) ensures plasma samples (900,000 liters) necessary for the French Fractionation and Biotechnology Laboratory (LFB) to manufacture blood-derived medicines. However, these levies only cover 35% national needs for immunoglobulins. These samples are carried out in accordance with an ethical model based on volunteerism, anonymity, non-commodification of the human body and on the safety of donors by limiting plasma samples to a maximum of 24 times per year. In contrast, it is important to emphasize that the rest of the immunoglobulins are made from plasma that comes from paid donations in the United States. America, where these samples can reach up to 104 times per year. In order to respond to an issue of national sovereignty in the field of medicines derived from blood, the French Blood Establishment (EFS) is proposing a plasma plan with the aim of responding, over the coming years, to a constantly increasing demand for plasma throughout the world and reaching the 1,400,000 liters necessary for the French blood laboratory. fractionation and biotechnologies (LFB). Thus, he asks how the Government plans to finance the French Blood Establishment (EFS) for this plasma plan which requires significant real estate, material and human resources and the mobilization of EFS teams to recruit and retain new donors.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.